ESC 365 - Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy

HFA Premium Access

Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy

Session: Young Investigator Award: basic science

Topic: Cardiomyopathies

Speaker: Mr T. Eijgenraam (Groningen, NL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Mr Tim Eijgenraam

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

3 more presentations in this session

DWORF diminishes clustering of phospholamban in a PLN-R14del cardiomyopathy mouse model and extends life span

Speaker: Ms N. Stege (Groningen, NL)

Immune checkpoints as novel mechanism in heart failure and predictors of outcomes

Speaker: Doctor W. Meijers (Rotterdam, NL)

Electrophysiological anomalies associated with a noonan syndrome mutation in RAF1 contribute to the development of cardiac arrhythmias

Speaker: Doctor F. Haghighi (Goettingen, DE)

Access the full session

Young Investigator Award: basic science

Speakers: Mr T. Eijgenraam, Ms N. Stege, Doctor W. Meijers, Doctor F. Haghighi

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources